HEALTHCOR HOLDINGS INC, DEF 14A, 1997-04-22

HEALTHCOR HOLDINGS INC
DEF 14A, 1997-04-22
MISC HEALTH & ALLIED SERVICES, NEC

Previous: EARTHLINK NETWORK INC, DEF 14A, 1997-04-22

Next: GEO PETROLEUM INC, 8-K, 1997-04-22

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934

Filed by the Registrant [X]

Filed by a Party other than the Registrant [ ]

Check the appropriate box:

[ ] Preliminary Proxy Statement
[ ] Confidential, for Use of the Commission only (as permitted by Rule
14a-6(e)(2))
[X] Definitive Proxy Statement
[ ] Definitive Additional Materials
[ ] Soliciting Material Pursuant to ss. 240.14a-11(c) or ss. 240.14a-12

HEALTHCOR HOLDINGS, INC.
(Name of Registrant as Specified in its Charter)

_____________________________________________________________________
(Name of Person(s) Filing Proxy Statement if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

[X] No fee required.

[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

1. Title of each class of securities to which transaction applies:

2. Aggregate number of securities to which transaction applies:

3. Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11:

4. Proposed maximum aggregate value of transaction:

5. Total fee paid:

[ ] Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.

1. Amount Previously Paid:
2. Form, Schedule or Registration Statement No.:
3. Filing Party:
4. Date Filed:
<PAGE>
HEALTHCOR HOLDINGS, INC.

Dallas, Texas

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
THURSDAY, JUNE 5, 1997

To the Stockholders of HealthCor Holdings , Inc.

The 1997 Annual Meeting of Stockholders (the "Annual Meeting") of
HealthCor Holdings, Inc., a Delaware corporation (the "Company"), will be held
on Thursday, June 5, 1997, at 10:00 a.m., local time, at the Company's executive
offices, 8150 North Central Expressway, Suite M-2000, Dallas, Texas 75206 for
the following purposes:

1. To elect six directors to serve until the 1998 Annual Meeting of
Stockholders;

2. To ratify the selection of Arthur Andersen LLP as independent
auditors for the Company for the fiscal year ending December 31,
1997; and

3. To transact all other business that may properly come before such
meeting or any adjournment(s) thereof.

The close of business on Thursday, April 10, 1997 has been fixed as the
record date for the determination of Stockholders entitled to notice of, and to
vote at, the Annual Meeting or any adjournment(s) thereof. Only holders of
record of the Company's Common Stock at the close of business on the record date
are entitled to notice of, and to vote at, the Annual Meeting. The Company's
stock transfer books will not be closed. A complete list of stockholders
entitled to vote at the Annual Meeting will be available for examination by any
Company stockholder at the Company's headquarters, 8150 North Central
Expressway, Suite M-2000, Dallas, Texas 75206, for purposes pertaining to the
Annual Meeting, during normal business hours for a period of 10 days prior to
the Annual Meeting, and at the time and place of the Annual Meeting.

You are cordially invited to attend the Annual Meeting. WHETHER OR NOT YOU
EXPECT TO ATTEND IN PERSON, YOU ARE URGED TO SIGN, DATE AND MAIL THE ENCLOSED
PROXY CARD AS SOON AS POSSIBLE SO THAT YOUR SHARES MAY BE REPRESENTED AND VOTED
AT THE ANNUAL MEETING. A self-addressed, postage prepaid envelope is enclosed
for your convenience. You may revoke your proxy by following the procedures set
forth in the accompanying Proxy Statement.

By order of the Board of Directors

HEALTHCOR HOLDINGS, INC.

Stephen L. Cohen
Secretary
April 30, 1997
<PAGE>
[GRAPHIC OMITTED]

HEALTHCOR HOLDINGS, INC.

8150 North Central Expressway, Suite M-2000
Dallas, Texas 75206
(214) 692-4333

PROXY STATEMENT

SOLICITATION AND REVOCABILITY OF PROXIES

The enclosed proxy is solicited by and on behalf of the Board of Directors
of the Company for use at the Annual Meeting to be held on Thursday, June 5,
1997, at 10:00 a.m., local time, at the Company's executive offices, 8150 North
Central Expressway, Suite M-2000, Dallas, Texas, or at any adjournment(s)
thereof. The solicitation of proxies by the Board of Directors of the Company
(the "Board of Directors") will be conducted primarily by mail. In addition,
officers, directors and employees of the Company may solicit proxies personally
or by telephone, telegram or other forms of wire or facsimile communication.
These persons will receive no special compensation for any solicitation
activities. The Company will, upon request, reimburse brokers, custodians,
nominees and fiduciaries for reasonable expenses incurred by them in forwarding
proxy material to beneficial owners of the common stock of the Company ("Common
Stock"). The costs of the solicitation will be borne by the Company. This proxy
statement and the form of proxy were first mailed to stockholders of the Company
on or about April 30, 1997.

The enclosed proxy, although executed and returned, may be revoked at any
time prior to the voting of the proxy (i) by the execution and submission of a
revised proxy bearing a later date, (ii) by written notice of revocation to the
Secretary of the Company at the address set forth above, or (iii) by voting in
person at the Annual Meeting. In the absence of such revocation, shares
represented by the proxies will be voted at the Annual Meeting.

1
<PAGE>
At the close of business on April 10, 1997, the record date for the
determination of shareholders entitled to notice of and to vote at the Annual
Meeting, there were outstanding 10,030,465 shares of Common Stock, each share of
which is entitled to one vote. Common Stock is the only class of outstanding
securities of the Company entitled to notice of and to vote at the Annual
Meeting.

A. ELECTION OF DIRECTORS

Six directors are to be elected at the Annual Meeting, and, if elected,
will serve until the Company's Annual Meeting of Stockholders in 1998 and until
their respective successors shall have been duly elected and qualified. Each of
these nominees for director currently serves as a director of the Company. Under
the Bylaws of the Company and consistent with Delaware law, directors shall be
elected by plurality vote at each annual meeting of stockholders at which a
quorum is present and, accordingly, abstentions and "broker non-votes" will have
no effect on the election of directors except in determining if a quorum is
present. A broker non-vote occurs if a broker or other nominee does not have
discretionary authority and has not received instructions with respect to a
particular item. Stockholders may not cumulate their votes in the election of
directors.

Unless otherwise instructed or unless authority to vote is withheld, the
enclosed proxy, if signed and returned, will be voted for the election of the
nominees listed below. Although the Board of Directors does not contemplate that
any of the nominees will be unable to serve, if such a situation arises prior to
the Annual Meeting, the persons named in the enclosed proxy will vote for the
election of such other person(s) as may be nominated by the Board of Directors.

THE BOARD OF DIRECTORS RECOMMENDS THE ELECTION OF MM. BAZZLE AND FINLEY,
AND MESSRS. BANTON, BAZZLE, CRATES AND FOSTER TO THE BOARD OF DIRECTORS.

The following table sets forth certain information regarding the director
nominees of the Company:

SERVED AS DIRECTOR'S
NAME AGE POSITION DIRECTOR SINCE TERM ENDING

S. Wayne Bazzle 61 Chairman of the Board 1989 1998
and Chief Executive
Officer
Cheryl C. Bazzle 49 President and Chief 1991 1998
Operating Officer
Julian W. Banton (1) 56 Director 1997 1998
Robert B. Crates (1) 34 Director 1992 1998
Jane B. Finley (2) 50 Director 1996 1998
Michael J. Foster (2) 44 Director 1991 1998
- -------------------
(1) Member of the Compensation Committee
(2) Member of the Audit Committee.

2
<PAGE>
Mr. Bazzle has served as the Chairman of the Board and Chief Executive
Officer of the Company since the Company's incorporation in October 1989. In
addition, Mr. Bazzle served as President of the Company from October 1989 to
October 1991. From October 1985 to October 1989, Mr. Bazzle served as Chairman
of the Board and Chief Executive Officer of HealthCor, Inc., a predecessor of
the Company. From September 1983 to September 1985, Mr. Bazzle served as a
consultant to Concepts of Care, Inc., a home health care company. Mr. Bazzle was
President and Chief Executive Officer of Drum Financial Corporation, a publicly
traded insurance and financial services corporation from 1976 to 1981. Prior
thereto, Mr. Bazzle was employed with the Bank of Virginia, where he served as
President and Chief Administrative Officer from 1973 to 1976. Mr. Bazzle is
married to Cheryl C. Bazzle.

Ms. Bazzle has served as the President, Chief Operating Officer and
Director of the Company since 1991. From 1989 to 1991, Ms. Bazzle served as
Senior Vice President of the Company. From December 1987 to October 1989, Ms.
Bazzle served in various capacities for HealthCor, Inc., a predecessor of the
Company, including serving as Senior Vice President, Chief Operating Officer and
President. From September 1985 to December 1987, Ms. Bazzle served in various
capacities for Concepts of Care, Inc. From September 1981 to October 1985, Ms.
Bazzle operated an equipment leasing company which she founded. Ms. Bazzle is
married to S. Wayne Bazzle.

Mr. Banton has served as a Director of the Company since February 1997.
Mr. Banton is Chairman, President, and Chief Executive Officer of SouthTrust
Bank of Alabama, N.A. From 1982 to 1985 he managed commercial banking at
SouthTrust Bank of Alabama, N.A. He was named President in 1985 and Chairman,
President and Chief Executive Officer in 1988. From 1965 to 1982 Mr. Banton was
employed by Signet Bank in Richmond in various capacities, including supervising
Corporate and International Banking. Mr. Banton previously served on the
Company's Board of Directors from 1992 to 1994.

Mr. Crates has served as a Director of the Company since June 1992 and was
elected to the Board of Directors in connection with the purchase by LKCM
Venture Partners I, Ltd. ("LKCM Venture Partners") of Series B Preferred Stock.
Since December 1995, Mr. Crates has been a principal of Crates Thompson Capital,
Inc., an investment company engaged primarily in the management of a private
equity investment fund. From May 1988 to November 1995, Mr. Crates served as a
Vice President of Luther King Capital Management, an investment advisory firm.
In that capacity, Mr. Crates, individually and as President of RBC Investment
Corp., served as the general partner of LKCM Venture Partners I, Ltd. From
October 1994 to January 1995, Mr. Crates concurrently served as Interim Chairman
and Chief Executive Officer of Eddie Haggar Limited, Inc., a company in which
LKCM Venture Partners had an investment and which filed for protection under
federal bankruptcy laws.

Ms. Finley has served on the Board of Directors since October 1996. Since
1992, Ms. Finley has been an Assistant Professor and Coordinator of the
Accounting Program at Belmont University in Nashville, Tennessee. Ms. Finley was
a Partner in the Consulting Practice of Deloitte & Touche from 1983 to 1992, and
with KPMG Peat Marwick as Manager in the Information Systems practice from 1980
to 1983.

3
<PAGE>
Mr. Foster has served as a Director of the Company since October 1991 and
was elected to the Board of Directors in connection with the purchase by RFE
Investment Partners IV, L.P. ("RFE IV") of Series B Preferred Stock. Since 1989,
Mr. Foster has been employed by RFE Management Corp., an investment manager of
several private equity investment funds, and a general partner of RFE Associates
IV, L.P., the general partner of RFE IV. Prior thereto, Mr. Foster was a partner
with the law firm of O'Sullivan Graev & Karabell. Mr. Foster has previously
served as a director of Community Health Systems, Inc. and ReLife, Inc. Mr.
Foster has served on the Board of Directors of Sterling Health Care Corporation,
a company which, together with its subsidiaries, in December 1996 filed for
protection under federal bankruptcy laws

The director nominees of the Company will hold office until the 1998
Annual Meeting of stockholders of the Company and until their successors are
duly elected and qualified, or until their earlier death, resignation,
disqualification or removal from office.

The following table sets forth information regarding the executive officer
of the Company who is not a director of the Company:

NAME AGE POSITION

Susan L. Belske 50 Senior Vice President, Chief Financial
Officer and Treasurer

Ms. Belske has served as Senior Vice President, Chief Financial Officer
and Treasurer of the Company since August 1996. From April 1993 until August
1996, Ms. Belske served as Vice President and Treasurer of the Company. From
1987 to 1993, Ms. Belske served as Vice President and Chief Financial Officer of
Nurse Finders, Inc. From 1981 to 1987, she served as Vice President and Chief
Financial Officer of Kimberly Services, Inc., the predecessor to Kimberly
Quality Care. Prior to 1981, Ms. Belske was employed by Ernst & Young for 11
years. Ms. Belske is a certified public accountant.

The executive officer named above was appointed to serve in such capacity
until her successor has been duly appointed or until her earlier death,
disqualification, retirement, resignation or removal from office.

DIRECTORS' MEETINGS AND COMMITTEES OF THE BOARD OF DIRECTORS

The Board of Directors held four meetings during fiscal year 1996. Each of
the directors attended at least 75% of the aggregate total meetings of the Board
of Directors and any committee on which such director served.

The Board of Directors currently has two standing committees, the Audit
Committee and the Compensation Committee. The Audit Committee, which currently
consists of Ms. Finley and Mr. Foster, will confer periodically with
representatives of the Company's independent auditors to review the general
scope of the annual audit, including consideration of the Company's accounting

4
<PAGE>
practices and procedures and system of internal accounting controls, and reports
to the Board of Directors with respect thereto. The Compensation Committee,
which currently consists of Messrs. Banton and Crates, meets periodically to
review and make recommendations with respect to the annual compensation of the
Company's executive officers.

COMPENSATION OF DIRECTORS

Each director of the Company who is not an officer, employee or affiliate
of the Company receives a $1,000 fee for each meeting of the Board of Directors
attended by such director and a $500 per month retainer. In addition, directors
of the Company are reimbursed for their reasonable out-of-pocket expenses in
connection with their travel to and attendance at meetings of the Board of
Directors or committees thereof.

In October 1996, the Company granted Ms. Finley options to purchase 5,000
shares of Common Stock at $11.50 per share vesting over a five-year period and
exercisable through October 2006.

In February 1997, the Company granted Mr. Banton options to purchase 5,000
shares of Common Stock at $9.50 per share vesting over a five-year period and
exercisable through February 2007. Prior to his election to the Board of
Directors, Mr. Banton held vested options to purchase 7,500 shares of Common
Stock at a weighted average exercise price of $3.39 per share.

The following table sets forth the compensation paid by the Company to the
Chief Executive Officer and the two next most highly compensated executive
officers (the "Named Executive Officers") for services rendered in all
capacities during fiscal 1996 and 1995.
<TABLE>
<CAPTION>
LONG-TERM
COMPENSATION
AWARDS (1)
STOCK OTHER
ANNUAL COMPENSATION OPTIONS ANNUAL ALL OTHER
YEAR SALARY(2) BONUS(3) SHARES COMPENSATION(4) COMPENSATION(5)
<S> <C> <C> <C> <C> <C> <C>
S. Wayne Bazzle 1996 $275,000 $96,250 0 $2,250 $12,060
Chairman of the Board 1995 $240,000 $72,000 0 $2,250 $12,060
and Chief Executive
Officer

Cheryl C. Bazzle 1996 $225,000 $78,7500 0 $2,250 $6,591
President and 1995 $200,000 $60,000 0 $2,250 $6,591
Chief Operating Officer

Susan L. Belske 1996 $140,000 $20,0000 0 $1,927 $0
Senior Vice President, 1995 $120,000 $15,000 0 $1,927 $0
Chief Financial Officer
and Treasurer
</TABLE>
- -----------------------

5
<PAGE>
(1) The Company did not grant any stock options, stock appreciation rights or
make any long-term incentive plan payments to any of the Named Executive
Officers in 1995 or 1996.

(2) Represents annual salary, including compensation deferred by the Named
Executive Officer pursuant to the Company's 401(k) Plan.

(3) The Company's executive officers are entitled to receive bonuses depending
on the Company's achievement of certain performance criteria. Amounts
represent bonuses accrued for each year's performance, but paid in the
subsequent year.

(4) Represents the Company's contribution to its 401(k) Plan made on behalf of
the Named Executive Officers.

(5) Amounts represent automobile allowances and expenses.

The following table sets forth, as of December 31, 1996, the number of
stock options and the value of unexercised stock options held by the Named
Executive Officers. As of December 31, 1996, there had been no stock options
exercised by any Named Executive Officer.

FISCAL YEAR-END OPTION VALUES

NUMBER OF
SHARES UNDERLYING VALUE OF UNEXERCISED
UNEXERCISED OPTIONS AT IN-THE-MONEY OPTIONS AT
DECEMBER 31, 1996 DECEMBER 31, 1996 (1)
-------------------------- --------------------------
EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE

S. Wayne Bazzle
Chairman of the Board 0 0 0 0
and Chief Executive
Officer

Cheryl C. Bazzle
President and Chief 0 0 0 0
Operating Officer

Susan L. Belske
Senior Vice President, 12,500 7,500 $75,310 $33,370
Chief Financial Officer
and Treasurer
- ------------------
(1) Based on the last sale price of $9.00 on December 31, 1996 as reported on
the Nasdaq National Market less the weighted average per share exercise
price of $4.06 for 12,500 exercisable options and the per share exercise
price of $5.20 for 7,500 unexercisable options.

BONUS PLAN

The executive officers and certain other members of corporate management
are eligible to receive cash bonuses in addition to their base salaries. The
bonus plan for executive officers and corporate management is based upon
individual performance and the Company's financial results for the fiscal year.
Total bonuses paid to executive officers for fiscal 1996 were approximately
$195,000. Certain other corporate officers, corporate office management
personnel and field managers are eligible to receive bonuses based on individual
performance goals and Company

6
<PAGE>
performance. The executive officers' bonus plan is reviewed and approved by the
Compensation Committee of the Board of Directors. All other bonuses are reviewed
and approved by the executive officers.

STOCK OPTION PLANS

For a description of the Company's 1989 Stock Option Plan and 1996
Long-Term Incentive Plan, see Appendices A and B, respectively.

EMPLOYEE STOCK OWNERSHIP PLAN

The Board of Directors adopted an Employee Stock Ownership Plan ("ESOP"),
effective as of April 1, 1990, for eligible employees. The ESOP is an employee
stock ownership plan that is intended to satisfy the applicable qualification
requirements for such plans as set forth in the Internal Revenue Code. The ESOP
is designed to invest primarily in the shares of the Company's Common Stock.

Contributions to the ESOP of Common Stock and cash by the Company, when
declared at the discretion of the Board, are allocated to the accounts of
participants based on the ratio each participant's compensation for the year
bears to all participants' compensation for that year. Participants are not
vested in any amounts allocated to them until they have completed at least 1,000
hours of service per year for one year. After five such years, the participant
is 100% vested in such amounts. Generally, a participant also will be fully
vested upon attaining age 65 or in the event of total and permanent disability,
death or termination of the ESOP.

Shares of Common Stock, together with any other ESOP assets, are held by a
trustee appointed by the Company. Under the ESOP, each participant has a right
to direct the trustee as to the manner in which shares of Common Stock allocated
to his or her account, as well as a portion of the shares of Common Stock held
by the trustee pending allocation to the participant accounts, are to be voted
at each meeting of the Company stockholders. Allocated shares for which no
timely instructions are received will be voted by the trustees proportionally in
the manner as the shares for which voting instructions were received.

Upon leaving the Company, a participant is entitled to the vested amounts
which have been allocated to his or her account. Distributions of such amounts
will be made after the ESOP valuation date three years after an employee leaves
the Company. If a participant dies before receiving vested benefits from the
ESOP, then ESOP assets held for such participant will be distributed to the
participant's beneficiary. Under the ESOP, participants and beneficiaries with
account balances in excess of $3,500 will receive ESOP distributions in the form
of Common Stock and cash in lieu of any fractional shares. Account balances of
less than $3,500 will be paid in cash.

401(K) PLAN

The Company sponsors the HealthCor Holdings, Inc. Employees' Savings Plan
(the "401(k) Plan"). All employees who are employed by the Company and are at
least 21 years of age are eligible to participate upon employment with the
Company. Employees may contribute to the

7
<PAGE>
401(k) Plan up to 10% of their current compensation, subject to a statutory
prescribed annual limit. The 401(k) Plan provides that the Company will make
regular matching contributions to the 401(k) Plan each year in the amount of 25%
of the participant's contribution, up to 6% of the participant's compensation.
Employee contributions and the Company's matching contributions are deposited
with a corporate trustee and invested in various funds at the discretion of the
participant. The Company's contribution, if any, vests over five years or
earlier upon attainment of retirement at age 65, retirement for disability,
death or termination of the 401(k) Plan. Distributions may be made from a
participant's account in the form of a lump sum upon termination of employment,
retirement, disability, death or in the event of financial hardship. The 401(k)
Plan is intended to qualify under Section 401 of the Internal Revenue Code so
that contributions by employees or by the Company to the 401(k) Plan, and income
earned on such contributions, are not taxable to employees until withdrawn from
the 401(k) Plan.

EMPLOYMENT AGREEMENTS

The Company does not have employment agreements with any executive officer
of the Company.

AUDIT COMMITTEE INTERLOCK AND INSIDER PARTICIPATION

Mr. Foster currently serves as a member of the Audit Committee and is a
general partner of RFE Associates IV, L.P., the general partner of RFE
Investment Partners IV, L. P. Mr. Foster receives no compensation from the
Company for serving as a Director of the Company. Compensation of the other
non-employee members of the Board of Directors is determined by the entire Board
of Directors with a view to attracting and retaining talented individuals to
serve as directors.

THE FOLLOWING REPORT OF THE COMPENSATION COMMITTEE AND THE SHAREHOLDER
RETURN PERFORMANCE PRESENTATION THAT APPEARS IMMEDIATELY AFTER SUCH REPORT SHALL
NOT BE DEEMED TO BE SOLICITING MATERIAL OR TO BE FILED WITH THE SECURITIES AND
EXCHANGE COMMISSION UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES EXCHANGE
ACT OF 1934 OR INCORPORATED BY REFERENCE IN ANY DOCUMENT SO FILED.

COMPENSATION COMMITTEE REPORT ON EXECUTIVE COMPENSATION

The Compensation Committee (the "Committee") established compensation
policies and made the compensation decisions described herein for 1996. The
Board of Directors has responsibility for administering the Company's 1989 Stock
Option Plan and 1996 Long-Term Incentive Plan, described herein at Appendices A
and B, respectively, including the full and final authority regarding the
selection of award recipients and the size and terms of option grants. The

8
<PAGE>
Committee's compensation policies were applied to each of the Named Executive
Officers in the same manner.

The Committee believes that in order for the Company to succeed it must be
able to attract and retain qualified executives. The objectives of the Committee
in determining the type and amount of executive officer compensation are to
provide a compensation package consisting of a base salary, bonus, and long term
incentives that allows the Company to attract and retain talented executive
officers and to align their interests with those of the shareholders.

In 1993, the U.S. Congress enacted Section 162(m) of the Code and the U.S.
Treasury Department promulgated regulations thereunder that prevent publicly
traded companies from receiving tax deductions on certain compensation paid to
certain executive officers in excess of $1.0 million. For 1996, the amount of
compensation (as defined for Code Section 162(m) purposes) paid to the Company's
executive officers does not exceed the $1.0 million pay limit and will most
likely not be affected by the statute and regulations in the near future.
Nonetheless, the Committee is reviewing the statute and final regulations and,
if appropriate, will take necessary actions in the future to minimize the loss
of tax deductions related to compensation.

BASE SALARY

During fiscal 1996, the base salaries for the Named Executive Officers
were determined at the discretion of the Committee and were intended to be
competitive with executive salaries in the median range for companies of similar
size and stage of growth in the home health care industry based on the
subjective view of the Committee and the internal responsibilities of such
officers as determined in the view of the Committee based on the Committee
members' business experience. The Chairman of the Board and Chief Executive
Officer's base salary was determined in this manner to be $275,000, as noted in
the summary compensation table. The Committee believes that the base salaries
for fiscal 1996 of the executive officers were within the median range for
comparable positions for similar companies in the home health care industry. The
Committee engaged a consultant to prepare a comparison of executive salaries
paid by other companies, which together with the experience of the Committee
members within the home health care industry and association with other
companies formed the basis for their base salary decisions. See "Election of
Directors" for a description of the home health care and business experience of
each Committee member.

BONUS

Annual incentive bonuses are intended to reflect the Committee's belief
that a significant portion of the annual compensation of each executive officer
should be contingent upon the performance of the Company, as well as the
individual contribution of each officer. Accordingly, all of the Named Executive
Officers of the Company are eligible for cash bonuses based upon the Company's
overall financial performance and the achievement of certain other goals. The
purpose of such bonuses is to reward and reinforce executive management's
commitment to achieve levels of annual profitability and return consistent with
increasing shareholder value.

9
<PAGE>
The Committee annually determines each executive's bonus level. The
Committee takes into account various qualitative and quantitative factors which
reflect the executive's position, longevity in office of each officer, level of
responsibility and ability to impact the Company's profitability and financial
success.

Cash bonuses are paid each year upon completion of the Company's annual
audit of the results of operations for the previous fiscal year by the Company's
outside auditors.

LONG TERM INCENTIVES

The Company did not award any incentive stock options in 1996 to any of
the Named Executive Officers. See table entitled "Option Grants in Last Fiscal
Year." All of the executive officers listed therein are significant stockholders
of the Company or have previously been granted substantial long-term incentives.
The Company has utilized this award in previous years to provide additional long
term incentives.

SHAREHOLDER RETURN PERFORMANCE PRESENTATION

Set forth below is a line graph comparing the percentage change in the
cumulative total return on the Company's Common Stock with the cumulative total
return of the CRSP Total Return Index for the Nasdaq National Market (U.S.
Companies) ("Nasdaq Market Index") and the CRSP Total Return Industry Index for
a peer group of home health care stocks ("Health Care Index") for the period
commencing on August 8, 1996(1) and ending on December 31, 1996.

COMPARISON OF CUMULATIVE TOTAL RETURN FROM
AUGUST 8, 1996 THROUGH DECEMBER 31, 1996(2)

[LINEAR GRAPH PLOTTED FROM DATA IN TABLE BELOW]

<TABLE>
<CAPTION>
08/08/96 08/30/96 09/30/96 10/31/96 11/29/96 12/31/96
-------- -------- -------- -------- -------- --------
<S> <C> <C> <C> <C> <C> <C>
HealthCor Holdings, Inc. (-10.0%) ............ 100.0 115.0 122.5 95.0 100.0 90.0
Home Care Composite, Inc. (-14.8%) ........... 100.0 90.0 86.0 81.5 79.0 85.2
NASDAQ (+11.0%) .............................. 100.0 105.0 110.8 107.7 111.6 111.0
</TABLE>
- --------
1 For purposes of this presentation, the Company has assumed that its
initial offering price per share of $10.00 would have been the closing
sales price on August 7, 1996, the day prior to the commencement of
trading. Trading in the Company's Common Stock commenced on August 8, 1996
and the Company's 1996 fiscal year ended on December 31, 1996.

2 Assumes that $100.00 was invested on August 8, 1996 in the Company's
Common Stock at the initial offering price of $10.00 per share and at the
closing sales price for each index on that date and that all dividends
were reinvested. No cash dividends have been declared on the Company's
Common Stock. Shareholder returns over such period should not be
considered indicative of future shareholder returns.

10
<PAGE>
CERTAIN TRANSACTIONS

RFE Investment Partners IV, L.P., the beneficial owner of more than five
percent of the outstanding Common Stock of the Company, has certain registration
rights with regard to shares of Common Stock held by it.

SECTION 16(A) REPORTING

Section 16(a) of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), requires the Company's Directors and Executive Officers, and
persons who own more than 10% of the Company's Common Stock, to file with the
Securities and Exchange Commission initial reports of ownership and reports of
changes in ownership of Common Stock and other equity securities of the Company.
Officers, Directors and greater than 10% stockholders are required by SEC
regulations to furnish the Company with copies of all Section 16(a) reports they
file. To the Company's knowledge and based solely on review of the copies of
such reports furnished to the Company during the period commencing August 8,
1996 and ending December 31, 1996, its Officers, Directors and greater than 10%
beneficial owners had complied with all applicable Section 16(a) filing
requirements.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS, DIRECTORS
AND MANAGEMENT

The following table sets forth information regarding the beneficial
ownership of the Common Stock of the Company as of April 20, 1997 with respect
to (i) each person known by the Company to own beneficially more than five
percent of the Company's Common Stock; (ii) each of the Company's Directors and
Named Executive Officers; and (iii) all Directors and executive officers as a
group. Pursuant to the rules of the Commission, in calculating percentage
ownership, each person is deemed to beneficially own his own shares subject to
options exercisable within 60 days after April 20, 1997, but options owned by
others (even if exercisable within 60 days) are deemed not to be outstanding
shares.

11
<PAGE>
NUMBER PERCENT OF CLASS

S. Wayne Bazzle (1) 2,612,270 26.7
Cheryl C. Bazzle (1)
8150 North Central Expressway
Suite M-2000
Dallas, Texas 75206
RFE Investment Partners IV, L.P. 2,158,528 21.5
36 Grove Street
New Canaan, Connecticut 06840
HealthCor Holdings, Inc. Employee 565,719 5.6
Stock Ownership Plan and Trust
Julian W. Banton(2) 8,500 *
Susan L. Belske(3) 13,770 *
Robert B. Crates(4) 16,662 *
Jane B. Finley 290 *
Michael J. Foster(5) 2,158,528 21.5
All directors and officers
as a group (7 persons) 4,810,020 47.7
- -------------------------
* Less than 1%.

(1) Of such shares, 1,175,000 shares are owned by S. Wayne Bazzle, 1,175,000
shares are owned by Cheryl C. Bazzle and 250,000 shares are owned by the
John Bradley Bazzle Trust (the "Trust"). S. Wayne Bazzle and Cheryl C.
Bazzle serve as trustees of the Trust. Each of Mr. and Ms. Bazzle disclaim
beneficial ownership of the shares owned by the other and the Trust.
Includes 12,270 shares beneficially owned through the Company's ESOP.

(2) 7,500 of such shares represent shares issuable upon exercise of vested
stock options.

(3) Includes 12,500 shares issuable upon exercise of vested stock options and
1,270 shares beneficially owned through the Company's ESOP.

(4) 8,331 of such shares are owned by Mr. Crates individually and 8,331 of
such shares are owned by RBC Investment Corp., a corporation of which Mr.
Crates is the sole director and officer and a shareholder.

(5) Michael J. Foster disclaims beneficial ownership of the shares held of
record by RFE Investment Partners, except to the extent of his partnership
interest in RFE Investment Partners.

B. RATIFICATION OF THE APPOINTMENT OF AUDITORS

The Board of Directors has appointed the firm of Arthur Andersen LLP,
which has served as independent auditors of the Company since 1992, as
independent auditors of the Company for the fiscal year ending December 31,
1997, and recommends ratification by the shareholders of such appointment. Such
ratification requires the affirmative vote of the holders of a majority of the
Common Stock of the Company entitled to vote on this matter and represented in
person or by proxy at the Annual Meeting. Accordingly, under the Bylaws of the
Company and in accordance with Delaware law, an abstention would have the same
legal effect as a vote against this proposal, but a broker non-vote would not be
counted for purposes of determining whether a majority had

12
<PAGE>
been achieved. The persons named in the accompanying proxy intend to vote for
ratification of such appointment unless instructed otherwise on the proxy.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" THIS PROPOSAL.

In the event the appointment is not ratified, the Board of Directors will
consider the appointment of other independent auditors. The Board of Directors
may terminate the appointment of Arthur Andersen LLP as the Company's
independent auditors without the approval of the stockholders of the Company
whenever the Board of Directors deems such termination necessary or appropriate.
A representative of Arthur Andersen LLP is expected to attend the Annual Meeting
and will have the opportunity to make a statement, if such representative
desires to do so, and will be available to respond to appropriate questions.

ANNUAL REPORT

The 1996 Annual Report of the Company accompanies this Proxy Statement.

STOCKHOLDER PROPOSALS

Any stockholder who wishes to submit a proposal for inclusion in the proxy
material and for presentation at the Company's 1998 Annual Meeting of
Stockholders must forward such proposal to the Secretary of the Company at the
address indicated on the second page of this proxy statement, so that the
Secretary receives it no later than January 2, 1998.

13
<PAGE>
COPIES OF THE COMPANY'S ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED
DECEMBER 31, 1996, AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION,
EXCLUDING EXHIBITS, ARE AVAILABLE WITHOUT CHARGE UPON WRITTEN REQUEST TO
HEALTHCOR HOLDINGS, INC., 8150 NORTH CENTRAL EXPRESSWAY, SUITE M-2000, DALLAS,
TEXAS 75206.

The Board of Directors does not know of any other matters that are to be
presented for action at the Annual Meeting. However, if any other matters
properly come before the Annual Meeting or any adjournment(s) thereof, it is
intended that the enclosed proxy will be voted in accordance with the judgment
of the persons voting the proxy.

By Order of the Board of Directors,

Stephen L. Cohen
SECRETARY

April 30, 1997

16
<PAGE>
APPENDIX A

1989 STOCK OPTION PLAN

GENERAL. The 1989 Stock Option Plan (the "1989 Incentive Plan") is
currently administered by the Board of Directors of the Company (the "Board").
Subject to the express provisions of the 1989 Incentive Plan, the Board may,
from time to time, determine the persons that will be granted options under the
1989 Incentive Plan, the number of shares of Common Stock subject to each option
and the exercise price, and the time or times when such options shall be granted
and may be exercised. The 1989 Incentive Plan provides that options granted
under the 1989 Incentive Plan may be "incentive stock options" ("ISOs") as
defined by the Internal Revenue Code of 1986, as amended (the "Code") or
Non-Qualified Stock Options. The maximum number of shares of Common Stock
available for grant under the Incentive Plan is 387,500. As of December 31,
1996, options to purchase 386,875 shares were outstanding under the Incentive
Plan with a weighted average exercise price of $5.56 per share. All of the
options granted to date under the Incentive Plan are exercisable over a ten year
period. All shares issuable upon options issued under the 1989 Plan have been
registered with the Commission on a registration statement on Form S-8 under the
Securities Act of 1933, as amended (the "Securities Act").

EMPLOYEES WHO MAY PARTICIPATE IN THE 1989 INCENTIVE PLAN. All officers,
employees and directors of the Company or any of its affiliates may be granted
options under the 1989 Incentive Plan; however, ISO's may be granted only to
full-time employees of the Company. On August 8, 1996 the registration statement
on Form S-1, pursuant to which the Company registered shares of its Common Stock
for sale to the public, was declared effective.

EXERCISE. Each option granted under the 1989 Incentive Plan is exercisable
at such times and under such conditions permissible under the terms of the
Incentive Plan as determined by the Committee at the time the option is granted.

Shares of Common Stock purchased upon exercise of options ("Option
Shares") shall at the time of purchase be paid for in full. To the extent that
the right to purchase shares has accrued under the 1989 Incentive Plan, options
may be exercised from time to time by written notice to the Company stating the
full number of shares with respect to which the option is being exercised,
accompanied by full payment for the shares by cash, check or surrender of other
shares of the Company's Common Stock having a fair market value on the date of
surrender equal to the aggregate exercise price of the shares as to which the
option is being exercised. An option may not be exercised for a fraction of a
share.

The exercise price of options granted under the Incentive Plan may not be
less than 100% of the fair market value of the Common Stock on the date of
grant. Absent a public market for the Common Stock, the Incentive Plan provides
for the fair market value per share of Common Stock to be determined by the
Board of Directors of the Company.

A-1
<PAGE>
NON-ASSIGNABILITY. No option shall be assignable or transferable otherwise
than by will or by the laws of descent and distribution. During the lifetime of
an optionee, the option is exercisable only by the optionee.

TERM. An option may not be granted with a term exceeding ten years.

The 1989 Incentive Plan will terminate on October 18, 1999; but the Board
of Directors of the Company may terminate the 1989 Incentive Plan at any time
prior thereto. Termination of the 1989 Incentive Plan shall not affect, without
the consent of the optionee, any option theretofore granted under the 1989
Incentive Plan.

TERMINATION OF RELATIONSHIP. In the event that an optionee terminates or
is terminated from his relationship with the Company and its affiliates for
reasons other than the optionee's death or disability, the optionee shall have
the right to exercise his options at any time within ninety days (or such other
period of time as is determined by the Committee at the time of grant of the
option) from the date of termination to the extent the optionee was entitled to
exercise the options at the date of such termination.

In the event that an optionee's relationship with the Company (or an
affiliate) is terminated because such optionee has become totally or permanently
disabled within the meaning of Section 22(e)(3) of the Code, the optionee shall
have the right to exercise his options at any time within six months (or such
other period of time not exceeding twelve months as is determined by the
Committee at the time of grant of the option) from the date of termination of
his relationship due to disability, to the extent the optionee was entitled to
exercise the options immediately prior to such occurrence.

In the event an optionee dies before his relationship with the Company (or
an affiliate) otherwise terminates, the optionee's estate or beneficiary shall
have the right to exercise his options at any time within six months from the
date of death of the optionee, but only to the extent of the right to exercise
that would have accrued had the optionee continued living and remained an
employee or consultant of the Company (or an affiliate) during the six month
period following the date of death.

If an optionee dies within thirty days (or such other period of time not
exceeding three months as is determined by the Committee at the time of grant of
the option) after the termination of his relationship with the Company (or an
affiliate), the optionee's estate or beneficiary shall have the right to
exercise the optionee's options at any time within six months following the date
of death of the optionee.

In the event of the proposed dissolution or liquidation of the Company,
all options under the 1989 Incentive Plan will terminate immediately prior to
the consummation of such proposed action, unless otherwise provided by the
Committee. In the event of the proposed sale of all or substantially all of the
assets of the Company, or the merger of the Company with or into another
corporation, all options under the Incentive Plan shall be assumed or equivalent
options shall be substituted by such successor corporation or a parent or
subsidiary of such successor corporation,

A-2
<PAGE>
unless the Committee determines in the exercise of its sole discretion and in
lieu of such assumption or substitution, that the optionee shall have the right
to exercise the option as to all of the option shares, including shares as to
which the option would not otherwise be exercisable.

ADJUSTMENTS TO OPTIONS. In the event of an increase or decrease in the
number of outstanding shares of Common Stock as a result of a recapitalization,
stock dividend or other event, which increase or decrease is effected without
receipt of consideration by the Company, the number of shares for which options
may be granted under the 1989 Incentive Plan, the number of shares covered by
each outstanding option and the exercise price thereof shall be proportionately
adjusted by the Committee, subject to any required action by the shareholders of
the Company.

AMENDMENT. The Board of Directors of the Company may, from time to time,
alter, amend, suspend, or discontinue the 1989 Incentive Plan, or alter or amend
any and all option agreements granted thereunder; provided, however, that no
such action of the Board of Directors, without the approval of the shareholders
of Company, may alter the provisions of the 1989 Incentive Plan so as to (i)
increase the number of shares of Common Stock subject to the 1989 Incentive Plan
(except as described above), (ii) change the designation of the class of
employees or consultants eligible to be granted options under the Incentive
Plan, or (iii) materially amend the 1989 Incentive Plan.

FEDERAL INCOME TAX ASPECTS.

The 1989 Incentive Plan is intended to qualify as an ISO plan under
Section 422 of the Code. If the 1989 Incentive Plan qualifies as such, then an
employee who receives an ISO under the 1989 Incentive Plan will not be deemed to
recognize income either at the time of the grant of the option or, assuming that
the optionee has been an employee at all times during the period beginning on
the date of the grant and ending three months prior to the date of exercise, at
the time of exercise of the option. In the case of an employee who is disabled
within the meaning of Section 22(e)(3) of the Code, the optionee must have been
an employee at all times during the period beginning on the date of grant and
ending on the date one year prior to the date of exercise. Gain or loss from the
sale or exchange of stock acquired upon such exercise will generally be treated
as long-term capital gain or loss, provided that such sale or exchange of the
shares does not occur within either the two year period after the date of the
granting of the option or the one year period after the date such shares were
acquired upon exercise. Under these circumstances, no deduction will be
allowable to the Company in connection with either the grant of such options or
the issuance of shares upon exercise thereof.

A-3
<PAGE>
on the disposition will be capital gain, and any loss will be capital loss. Such
capital gain or loss will be long-term capital gain or loss, depending on the
holding period of the shares. If an optionee recognizes compensation income as
the result of a disposition as described in this paragraph, the Company will be
entitled to a corresponding income tax deduction for its taxable year in which
or with which ends the taxable year of the employee in which the amount of
compensation income is included in such employee's gross income. The employee
will be deemed to have included such compensation income in gross income if the
Company satisfies in a timely manner the applicable Form W-2 or Form 1099
reporting requirements under Section 6041 or Section 6041A of the Code,
whichever is applicable, and the Treasury regulations thereunder.

Upon the exercise of an ISO, the excess of the fair market value of the
shares at the time of exercise over the option price will be an item of tax
preference subject to the alternative minimum tax provisions, unless the
optionee makes a disqualifying disposition of such shares as described in the
preceding paragraph.

(b) NON-ISOS

In the event that options granted under the 1989 Incentive Plan do not
qualify as ISOs, the employee will recognize compensation income upon the
receipt of such option if the option has a readily ascertainable fair market
value at the time of the grant, in the amount of the fair market value of the
option. In the opinion of the Company, the presently outstanding options did not
have a readily ascertainable fair market value at the time of their grant. If
the non-ISOs do not have a readily ascertainable fair market value, the employee
will not recognize income upon grant of the non-ISO, but will recognize
compensation income upon the exercise of the non-ISO if the shares issued
pursuant to such exercise are either transferable or not subject to substantial
risk of forfeiture. The amount of the income will be measured by the excess, if
any, of the fair market value of the shares at the time of exercise (determined
without regard to any restrictions other than a restriction which, by its terms,
will never lapse) over the amount paid as the exercise price of the non-ISO. If,
however, the employee is subject to certain restrictions with respect to the
shares received upon the exercise of the non-ISO, then the taxable income
realized by the employee will be deferred and will be measured based on the fair
market value of the shares at the time the restrictions lapse. Gain or loss on
the subsequent sale or exchange of such shares will be capital gain or loss if
the shares are a capital asset in the hands of the employee. Such capital gain
or loss will be long-term capital gain or loss depending on the holding period.
To the extent shares are received upon exercise of an option by a person subject
to Section 16(b) of the Exchange Act, such shares will be deemed not
transferable and subject to a substantial risk of forfeiture until such time as
the sale of such shares at a profit would no longer subject such person to suit
under Section 16(b) of the Exchange Act. An employee may elect, pursuant to
Section 83(b) of the Code, to be taxed in the taxable year in which a non-ISO is
exercised on the difference between the fair market value of the Common Stock on
the date of exercise and the exercise price.

A-4
<PAGE>
employee will be deemed to have included such compensation income in gross
income if the Company satisfies in a timely manner the applicable Form W-2 or
Form 1099 reporting requirements under Section 6041 or Section 6041A of the
Code, whichever is applicable, and the Treasury regulations thereunder.

As of April 16, 1997, the market value of the Common Stock as reported on
the Nasdaq National Market was $7.38 per share.

The following table provides information concerning options granted to
certain persons or groups pursuant to the Incentive Plan.

1989 INCENTIVE PLAN

OPTIONS OUTSTANDING
NAME AND POSITION AS OF APRIL 16, 1997
- ----------------- ----------------------
S. Wayne Bazzle 0
Chairman of the Board
and Chief Executive Officer

Cheryl C. Bazzle 0
President
and Chief Operating Officer

Susan L. Belske 20,000
Senior Vice President, Chief
Financial Officer and Treasurer

All Executive Officers 20,000
as a group (3 persons)

Current Non-Employee Directors 12,500(3)
as a group (4 persons)
- --------
(3) Represents 5,000 and 7,500 options held by Jane B. Finley amd Julian W.
Banton, respectively.

A-5
<PAGE>
APPENDIX B

1996 LONG-TERM INCENTIVE PLAN

1996 INCENTIVE PLAN. The Company may grant officers, directors and key
employees awards with respect to shares of Common Stock under the HeatlhCor
Holdings, Inc. 1996 LongTerm Incentive Plan (the "1996 Incentive Plan"). The
awards under the 1996 Incentive Plan include: (i) incentive stock options
qualified as such under U.S. federal tax laws, (ii) stock options that do not
qualify as incentive stock options, (iii) SARs and (iv) restricted stock awards.
The 1996 Incentive Plan authorizes the issuance of 237,500 shares of Common
Stock pursuant to the exercise of non-transferable options granted to
participating employees. As of December 31, 1996, options to purchase 6,000
shares were outstanding under the 1996 Incentive Plan with a weighted average
exercise price of $9.21 per share. All of the options granted to date under the
Incentive Plan are exercisable over a ten year period. All shares issuable upon
options issued under the 1996 Incentive Plan have been registered with the
Commission on a registration statement on Form S-8 under the Securities Act of
1933, as amended (the "Securities Act").

The 1996 Incentive Plan is administered by the Board which determines the
exercise price of each option under the 1996 Incentive Plan. However, the
exercise price for an incentive stock option must not be less than the fair
market value of the Common Stock on the date of the grant. Stock options may be
exercised as the Board determines but not later than ten years from the date of
grant in the case of incentive stock options. At the discretion of the Board,
holders may use shares of Common Stock to pay the exercise price, including
shares issuable upon exercise of the option.

An SAR may be awarded in connection with or separate from a stock option.
An SAR is the right to receive an amount in cash or stock equal to the fair
market value of a share of the Common Stock on the date of exercise less the
exercise price specified in the agreement governing the SAR (for SARs not
granted in connection with a stock option) or the exercise price of the related
stock option (for SARs granted in connection with a stock option). An SAR
granted in connection with a stock option will require the holder, upon
exercise, to surrender the related stock option or portion thereof relating to
the number of shares for which the SAR is exercised. The surrendered stock
option, or portion thereof, will then cease to be exercisable or transferable.
An SAR granted independently of a stock option will be exercisable as the Board
determines. The Board may limit the amount payable upon exercise of any SAR and
such amounts may be paid in cash or stock.

A restricted stock award is a grant of shares of Common Stock that is
nontransferable or subject to risk of forfeiture until specific conditions are
met. The restrictions will lapse in accordance with a schedule or other
conditions as the Board determines. During the restriction period, the holder of
a restricted stock award may, in the Board's discretion, have certain rights as
a stockholder, including the right to vote the stock subject to the award or to
receive dividends thereon. Restricted stock may also be issued upon exercise or
settlement of options or SARs.

B-1
<PAGE>
An award under the 1996 Incentive Plan may have change of control features
as the Board determines. Such change of control features may provide that upon
the change of control of the Company: (i) the holder of a stock option will be
granted a corresponding SAR, (ii) all outstanding SARs and options will become
immediately and fully vested and exercisable in full and (iii) the restriction
period on any restricted stock award will be accelerated and the restrictions
will expire. Outstanding options under the 1996 Incentive Plan have the
provision described in the preceding clause (ii). A "change in control" of the
Company means: (i) a person other than the Company, certain affiliated companies
or benefit plans, or a company a majority of which is owned directly or
indirectly by the stockholders of the Company becomes the beneficial owner of
50% or more of the voting power of the Company's outstanding voting securities;
(ii) a majority of the Board of Directors is not comprised of the members of the
Board of Directors on June 4, 1996, and persons whose elections as directors
were approved by those directors of their approved successors; (iii) the Company
merges or consolidates with another corporation or entity (whether the Company
or the other entity is the survivor), or the Company and the holders of the
voting securities of such other corporation or entity (or the stockholders of
the Company and such other corporation or entity) participate in a securities
exchange, other than a merger, consolidation or securities are converted into or
continue to represent securities having the majority of voting power in the
surviving company; or (iv) the Company liquidates or sells all or substantially
all of its assets, except sales to an entity having substantially the same
ownership as the Company.

If a restructuring of the Company occurs that does not constitute a change
in control of the Company, the Board may: (I) accelerate in whole or in part the
time of vesting and exercisability of any outstanding stock options and SARs, in
order to permit those stock options and SARs to be exercisable before, upon, or
after the completion of the restructuring; (ii) grant each option holder
corresponding SARs; (iii) accelerate in whole or in part the expiration of some
or all of the restrictions on any restricted stock award; (iv) if the
restructuring involves a transaction in which the Company is not the surviving
entity, cause the surviving entity to assume in whole or in part any one or more
of the outstanding awards under the 1996 Incentive Plan upon such terms and
provisions as the Board deems desirable; or (v) redeem in whole or in part any
one or more of the outstanding awards (whether or not then exercisable) in
consideration of a cash payment, adjusted for withholding obligations. A
restructuring generally is any merger of the Company or the direct or indirect
transfer of all or substantially all of the Company's assets (whether by sale,
merger, consolidation, liquidation, or otherwise) in one transaction or a series
of transactions.

The options granted in 1996 under the 1996 Incentive Plan to executive
officers automatically vest upon a change in control, termination of their
employment with the Company by the Company without cause or termination of their
employment with the Company by the officer for good reason.

TERMINATION OF RELATIONSHIP. In the event that an optionee terminates or
is terminated from his relationship with the Company and its affiliates for
reasons other than the optionee's death or disability, the optionee shall have
the right to exercise his options at any time within thirty days (or such other
period of time not exceeding three months as is determined by the Committee at
the time of grant of the option) from the date of termination to the extent the
optionee was entitled to exercise the options at the date of such termination.

B-2
<PAGE>
In the event that an optionee's relationship with the Company (or an
affiliate) is terminated because such optionee has become totally or permanently
disabled within the meaning of Section 22(e)(3) of the Code, the optionee shall
have the right to exercise his options at any time within six months (or such
other period of time not exceeding twelve months as is determined by the
Committee at the time of grant of the option) from the date of termination of
his relationship due to disability, to the extent the optionee was entitled to
exercise the options immediately prior to such occurrence.

In the event an optionee dies before his relationship with the Company (or
an affiliate) otherwise terminates, the optionee's estate or beneficiary shall
have the right to exercise his options at any time within six months from the
date of death of the optionee, but only to the extent of the right to exercise
that would have accrued had the optionee continued living and remained an
employee of the Company (or an affiliate) during the six month period following
the date of death.

ADJUSTMENTS TO OPTIONS. In the event of an increase or decrease in the
number of outstanding shares of Common Stock as a result of a recapitalization,
stock dividend or other event, which increase or decrease is effected without
receipt of consideration by the Company, the number of shares for which options
may be granted under the 1996 Plan, the number of shares covered by each
outstanding option and the exercise price thereof shall be proportionately
adjusted by the Committee, subject to any required action by the shareholders of
the Company.

In the event of the proposed dissolution or liquidation of the Company,
all options under the 1996 Plan will terminate immediately prior to the
consummation of such proposed action, unless otherwise provided by the
Committee. In the event of the proposed sale of all or substantially all of the
assets of the Company, or the merger of the Company with or into another
corporation, all options under the 1996 Plan shall be assumed or equivalent
options shall be substituted by such successor corporation or a parent or
subsidiary of such successor corporation, unless the Committee determines in the
exercise of its sole discretion and in lieu of such assumption or substitution,
that the optionee shall have the right to exercise the option as to all of the
option shares, including shares as to which the option would not otherwise be
exercisable.

AMENDMENT. The Board of Directors of the Company may, from time to time,
alter, amend, suspend, or discontinue the 1996 Plan, or alter or amend any and
all option agreements granted thereunder; provided, however, that no such action
of the Board of Directors, without the approval of the shareholders of Company,
may alter the provisions of the 1996 Plan so as to (i) increase the number of
shares of Common Stock subject to the 1996 Plan (except as described above),
(ii) change the designation of the class of key employees eligible to be granted
options under the 1996 Plan, or (iii) materially amend the 1996 Plan.

B-3
<PAGE>
FEDERAL INCOME TAX ASPECTS.

(a) ISOS

The 1996 Plan is intended to qualify as an ISO plan under Section 422 of
the Code. If the 1996 Plan qualifies as such, then an employee who receives an
ISO under the 1996 Plan will not be deemed to recognize income either at the
time of the grant of the option or, assuming that the optionee has been an
employee at all times during the period beginning on the date of the grant and
ending three months prior to the date of exercise, at the time of exercise of
the option. In the case of an employee who is disabled within the meaning of
Section 22(e)(3) of the Code, the optionee must have been an employee at all
times during the period beginning on the date of grant and ending on the date
one year prior to the date of exercise. Gain or loss from the sale or exchange
of stock acquired upon such exercise will generally be treated as long-term
capital gain or loss, provided that such sale or exchange of the shares does not
occur within either the two year period after the date of the granting of the
option or the one year period after the date such shares were acquired upon
exercise. Under these circumstances, no deduction will be allowable to the
Company in connection with either the grant of such options or the issuance of
shares upon exercise thereof.

If a disposition (as that term is defined in Section 424(c) of the Code)
of shares acquired pursuant to the exercise of an ISO is made within either the
two year period after the date of granting of the option or the one year period
after the date the shares were acquired (a "disqualifying disposition"), the
optionee will generally recognize compensation income at the time of disposition
equal to the excess of the fair market value of the shares at the time of
exercise over the option price (limited to the difference between the amount
realized by the employee on the sale of such shares and the exercise price). Any
such compensation income recognized as described in this paragraph will increase
the optionee's tax basis in his shares. If a disposition described in this
paragraph occurs in a taxable transaction, any gain in excess of compensation
income recognized on the disposition will be capital gain, and any loss will be
capital loss. Such capital gain or loss will be long-term capital gain or loss,
depending on the holding period. If an optionee recognizes compensation income
as the result of a disposition as described in this paragraph, the Company will
be entitled to a corresponding income tax deduction for its taxable year in
which or with which ends the taxable year of the employee in which the amount of
compensation income is included in such employee's gross income. The employee
will be deemed to have included such compensation income in gross income if the
Company satisfies in a timely manner the applicable Form W-2 or Form 1099
reporting requirements under Section 6041 or Section 6041A of the Code,
whichever is applicable, and the Treasury regulations thereunder.

B-4
<PAGE>
(b) NON-ISOS

In the event that options granted under the 1996 Plan do not qualify as
ISOs, the employee will recognize compensation income upon the receipt of such
option if the option has a readily ascertainable fair market value at the time
of the grant, in the amount of the fair market value of the option. In the
opinion of the Company, the presently outstanding options did not have a readily
ascertainable fair market value at the time of their grant. If the non-ISOs do
not have a readily ascertainable fair market value, the employee will not
recognize income upon grant of the non-ISO, but will recognize compensation
income upon the exercise of the non-ISO if the shares issued pursuant to such
exercise are either transferable or not subject to substantial risk of
forfeiture. The amount of the income will be measured by the excess, if any, of
the fair market value of the shares at the time of exercise (determined without
regard to any restrictions other than a restriction which, by its terms, will
never lapse) over the amount paid as the exercise price of the non-ISO. If,
however, the employee is subject to certain restrictions with respect to the
shares received upon the exercise of the non-ISO, then the taxable income
realized by the employee will be deferred and will be measured based on the fair
market value of the shares at the time the restrictions lapse. Gain or loss on
the subsequent sale or exchange of such shares will be capital gain or loss if
the shares are a capital asset in the hands of the employee. Such capital gain
or loss will be long-term capital gain or loss, depending on the holding period.
To the extent shares are received upon exercise of an option by a person subject
to Section 16(b) of the Exchange Act, such shares will be deemed not
transferable and subject to a substantial risk of forfeiture until such time as
the sale of such shares at a profit would no longer subject such person to suit
under Section 16(b) of the Exchange Act. An employee may elect, pursuant to
Section 83(b) of the Code, to be taxed in the taxable year in which a non-ISO is
exercised on the difference between the fair market value of the Common Stock on
the date of exercise and the exercise price.

In the case of compensation income recognized by an employee as described
above in connection with the exercise of an option, the Company will be entitled
to a corresponding income tax deduction for its taxable year in which or with
which ends the taxable year of the employee in which the amount of compensation
income is included in such employee's gross income. The employee will be deemed
to have included such compensation income in gross income if the Company
satisfies in a timely manner the applicable Form W-2 or Form 1099 reporting
requirements under Section 6041 or Section 6041A of the Code, whichever is
applicable, and the Treasury regulations thereunder.

As of April 16, 1997, the market value of the Common Stock as reported on
the Nasdaq National Market was $7.38 per share.

The following table provides information concerning options granted to
certain persons or groups pursuant to the 1996 Plan.

B-5
<PAGE>
1996 INCENTIVE AND NON-STATUTORY STOCK OPTION PLAN

OPTIONS OUTSTANDING
NAME AND POSITION AS OF APRIL 16, 1997
- ----------------- ----------------------
S. Wayne Bazzle 0
Chairman of the Board
and Chief Executive Officer

Cheryl C. Bazzle 0
President
and Chief Operating Officer

Susan L. Belske 0
Senior Vice President, Chief
Financial Officer and Treasurer

All Executive Officers 0
as a group (3 persons)

Current Non-Employee Directors 5,000(4)
as a group (4 persons)
- --------
4 Represents options held by Julian W. Banton

B-6
<PAGE>
- --------------------------------------------------------------------------------
HEALTHCOR HOLDINGS, INC.
8150 NORTH CENTRAL EXPRESSWAY, SUITE M-2000
DALLAS, TEXAS 75206

THIS PROXY IS SOLICITED ON BEHALF OF
THE BOARD OF DIRECTORS OF THE COMPANY

The undersigned hereby revoking all prior proxies, hereby appoints S. Wayne
Bazzle and Cheryl C. Bazzle, jointly and severally, with full power to act
alone, as my true and lawful attorneys-in-fact, agents and proxies, with full
and several power of substitution to each, to vote all the shares of Common
Stock of HealthCor Holdings, Inc. (the "Company") which the undersigned would be
entitled to vote if personally present at the Annual Meeting of Stockholders of
the Company to be held on June 5, 1997 and at any adjournments and postponements
thereof. The above-named proxies are hereby instructed to vote as shown on the
reverse side of this card.

COMMENTS/ADDRESS CHANGE: PLEASE MARK COMMENT/ADDRESS CHANGE ON REVERSE SIDE

(CONTINUED AND TO BE SIGNED ON OTHER SIDE)
- --------------------------------------------------------------------------------
^FOLD AND DETACH HERE^
<PAGE>
- --------------------------------------------------------------------------------

THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED AS Please mark
SPECIFIED HEREIN, BUT WHERE NO DIRECTION IS GIVEN IT your vote as [X]
WILL BE VOTED "FOR" PROPOSALS 1, 2 AND 3 IN THE MATTERS indicated in
THAT MAY PROPERLY COME BEFORE THE MEETING. this example

1. ELECTION OF DIRECTORS for the item set forth in the
accompanying proxy statement.

FOR all nominees WITHHOLD
listed below (except AUTHORITY MARK HERE FOR
as marked to the to vote for all nominees COMMENTS/ADDRESS
contrary) listed below CHANGE:

[ ] [ ] [ ]

S. Wayne Bazzle, Cheryl C. Bazzle, Julian W. Banton,
Robert B. Crates, Jane B. Finley, Michael J. Foster

WITHHELD FOR: (To withhold authority to vote for any individual
nominee, write the nominee's name in the space provided below.)

_________________________________________________________________

2. Ratification of Arthur Andersen LLP to serve as the Company's independent
auditors for 1997.

FOR AGAINST ABSTAIN

[ ] [ ] [ ]

3. In their discretion, upon such other business as may properly come before the
meeting.

FOR AGAINST ABSTAIN

[ ] [ ] [ ]

The undersigned(s) acknowledges receipt of the
Notice of 1997 Annual Meeting of Stockholders
and the proxy statement accompanying the same,
each dated April 30, 1997.

Please date this proxy and sign your name
exactly as it appears hereon. If there is more
than one owner, each should sign. When signing
as an agent, attorney, administrator, guardian
or trustee, please indicate your title as such.
If executed by a corporation this proxy should
be signed in the corporate name by a duly
authorized officer who should so indicate his or
her title.

Dated ___________________________________, 1997

_______________________________________________
Signature
_______________________________________________
Signature if held jointly

PLEASE DATE, SIGN AND RETURN THIS PROXY PROMPTLY
IN THE ENCLOSED ENVELOPE.
- --------------------------------------------------------------------------------
^FOLD AND DETACH HERE^